Inside Berkshire Hathaway, some investors think legendary CEO Warren Buffett may be laying the groundwork for a blockbuster business opportunity, spawned from the health care venture he recently formed with the leaders of Amazon and JPMorgan Chase.

While most of the national discussion about the high-profile venture has focused on its potential to reshape the U.S. health care system, interviews with two long-time Berkshire shareholders show that within Buffett World, it’s also seen as a chance to develop profit-making lines of business and new investment ideas.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy